TORONTO, ON / ACCESSWIRE / November 24, 2020 / Murchison Minerals Ltd. ("Murchison" or the "Company") (TSX-V:MUR)(OTC PINK:MURMF)  is pleased to announce the discovery of a new zinc, silver, gold and lead mineralization at Street Lake on the Brabant Lake project in Saskatchewan. The new mineralization consists of several grab samples collected 350 metres northwest of the northernmost tip of Street Lake during the 2020 summer prospecting program. The most significant sample was collected from a zone of extremely weathered outcrop (pictured below) where the rock has degraded almost entirely to rust coloured silt and sand, assayed 0.58% zinc, 0.17% lead and 32.4 g/t silver. The weathering was primarily affecting the mineralized zone and it is assumed that the oxidation of the sample may have significantly decreased the original zinc content of the primary rock.

Photo of Sample Location of 0.58% Zn, 0.17% Pb, 32.4 g/t Ag

Street Lake is located approximately 20 km northeast of the Brabant-McKenzie VMS Deposit. The area was staked based on a 2012 geophysical electromagnetic (EM) survey which highlighted a prospective conductor. A historic grab sample on the property collected by Great Bend Resources in 1987 assayed 1.19 g/t gold within a quartz vein. The 2020 prospecting work conducted by Murchison on the claim led to the discovery of this previously unknown zinc, lead, and silver mineralization.

The mineralization is located approximately 250 metres north-west of a series of EM conductors found along an 1,800 m long corridor observed in an airborne survey flown for First Graphite Corp. in 2012. The close proximity of the zinc, lead and silver mineralization to the EM conductors is encouraging and may indicate that the geophysical target is related to volcanogenic massive sulphide (VMS) mineralization similar to the Brabant-McKenzie Deposit. Limited historic diamond drilling by Hudson Bay Exploration and Development Company in 1977 on the far eastern extent of the conductive corridor intersected intervals of pyrite and graphite and included 3.05 metres of 0.1% zinc which is elevated well above background for the region. Follow-up prospecting is required to attempt to locate additional mineralization, and additional EM geophysical surveys are required to better locate the exact location of the historic EM conductors.

The area of deeply weathered zinc mineralization that was observed is approximately 4 m2 in size within an approximately 8 m2 outcrop. Sampling adjacent to the weathered zone in a rusty feldspar rich rock with disseminated galena and possible sericite alteration returned up to 0.38% lead and 18.1 g/t silver. An outcrop of rusty pegmatite was observed about 80 metres away and contained extensive quartz veining. Grab sampling of the pegmatite returned anomalous gold assays up to 0.38 g/t gold and 11.4 g/t silver.

Location Map of Street Lake 2020 Prospecting Results

Disseminated Fine Grained Galena Discovered Adjacent to Weathered Zinc Bearing Outcrop

Example of the Rusty Pegmatite with Anomalous Gold and Silver Assays Observed in Shallow Backpack Drill Hole

QA/QC

All rock samples were submitted to SRC Geoanalytical Laboratories in Saskatoon, Saskatchewan, Canada. They were analyzed twice using a partial and a total digest and ICP-OES. All samples were also analyzed for gold utilizing fire assay. SRC Geoanalytical Laboratories is an ISO certified and accredited laboratory.

Qualifying Statement

The foregoing scientific and technical disclosures have been reviewed by Andrew Masurat, P. Geo., and John Shmyr, P. Geo., qualified persons as defined by National Instrument 43-101. Mr. Masurat and Mr. Shmyr are independent consultants to Murchison and the Brabant-McKenzie project.

About the Brabant‐McKenzie VMS Project

The Brabant-McKenzie project is located 175 kilometres northeast of La Ronge, Saskatchewan and approximately three kilometres from the community of Brabant Lake. The area is accessed year-round via provincial Highway 102 and is serviced by grid power.

Brabant‐McKenzie VMS Deposit

The project consists of one mining lease, which hosts the Brabant-McKenzie VMS deposit, and additional mineral claims totalling 627 square kilometres, which cover approximately 57 kilometres of strike length over favourable geological horizons, multiple known mineralized showings and identified geophysical conductors.

About Murchison Minerals Ltd. (TSXV: MUR)

Murchison is a Canadian‐based exploration company focused on the exploration and development of the 100%-owned Brabant‐McKenzie zinc‐copper‐silver project in north‐central Saskatchewan. The Company also has a 100% interest in the HPM nickel‐copper‐cobalt project in Quebec. Murchison has 78.7 million shares issued and outstanding.

Additional information about Murchison and its exploration projects can be found on the Company's website at www.murchisonminerals.com. For further information, please contact:

Jean‐Charles (JC) Potvin, President and CEO
jcpotvin@murchisonminerals.com

Erik H Martin, CFO
Tel: (416) 350‐3776
info@murchisonminerals.com

Cathy Hume, CHF Capital Markets, CEO
Tel: 416-868-1079 x 231
cathy@chfir.com

Forward‐Looking Information

Certain information set forth in this news release may contain forward‐looking information that involves substantial known and unknown risks and uncertainties. This forward‐looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward‐looking information. The parties undertake no obligation to update forward‐looking information except as otherwise may be required by applicable securities law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Murchison Minerals Ltd.

ReleaseID: 618033

NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Madison Technologies Inc. (OTCQB:MDEX), a brand development and business accelerator company, is pleased to announce Posto Del Sole's inaugural jewelry launch: Brookland Jewelry. Located in Brooklyn and dedicated to giving back to its borough, Brookland Jewelry has created a collection of pendants and rings that reflect the Brooklyn motto, "In Unity There is Strength." The collection offers 14kt and sterling silver jewelry choices starting at $180.

Brooklyn, NY has an estimated population of 2.6 million with a very high population density of 36,732 people per square mile. With a rich history dating back over 350 years, immigrants continue to flock to this borough, making Brooklyn a great place to launch a borough themed jewelry brand.

Brookland Jewelry's holiday advertising and social media campaign will promote the "Unity Makes Strength" collection with 25% of the sales donated to the Brooklyn based Arthur Ashe Institute for Public Health.

"We keep the Brooklyn motto close to our hearts every day. We are thrilled to partner with the AAIUH in support of its vital mission and programs," says Jennifer Garfall, Chief Creative Officer at Posto Del Sole

Visit Brooklyn Jewelry's website, or follow them on Facebook, Instagram and Twitter.

About Madison Technologies Inc:
Madison Technologies is a brand development and business accelerator company. The company is focused on select consumer good segments that are deemed underserved and offer significant growth opportunities for our company.

About Posto Del Sole
Posto del Sole is a jewelry company focused on aggregating small designer brands via innovative and participatory digital channels. Led by former Tiffany & Co. executives, our team has the best design, product development, and sourcing expertise in the industry. This breadth and depth of experience is distinctly suited to helm a diverse portfolio of designer jewelry brands unified by their superb quality and craftsmanship. You can learn more at www.pdsbrands.com.

About Casa Zeta-Jones Brand
The CZJ product line will include a custom-designed handle and cartridge system, pre-care products, exclusive shaving products, and some of the best aftercare products on the market today. The Casa Zeta-Jones brand will transcend what is often considered a chore to a more pampering and lush women's shaving experience. You can learn more at www.czjlegs.com.

Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this press release may contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price.

CONTACT:
Jeff Canouse, MDEX, CEO
jeff@madisontech.io

SOURCE: Madison Technologies, Inc.

ReleaseID: 618065

Implements New Corporate Strategy to Focus on Precision Therapeutics for the Treatment of Cancer
Strengthens Pipeline by Acquiring a Proprietary Portfolio of Novel Adenosine Immuno-Modulator Compounds
Increased Cash Runway by Securing $500,000 of Gross Proceeds From an Existing Institutional Investor in October 2020

WESTLAKE VILLAGE, CA / ACCESSWIRE / November 24, 2020 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics for the treatment of cancer, today reported its financial results for the third quarter ended September 30, 2020.

Business Highlights

During the third quarter, the company continued to execute on implementing a new corporate strategy by strengthening its portfolio and securing additional capital to pursue long-term strategic objectives and create value for stakeholders.
In October 2020, we sold additional convertible debentures resulting in $500,000 from existing investors.
In October 2020, we announced that the company would strengthen its strategic collaboration with Ridgeway Therapeutics by reacquiring its novel immune-oncology precision targeting platform for the treatment of cancer through the cancellation of our prior licensing agreement.
Inspyr and Ridgeway will pursue the research and development of RT-AR001, a potential first-in-class adenosine receptor modulator. The novel delivery technology is differentiated by its microparticle formulation that allows for better tumor infiltration and enhanced outcomes when administered intra-tumorally and has demonstrated delayed tumor growth, reduced metastases and enhanced anti-tumor immune activities in pre-clinical studies.

The company is now in the process of commencing corporate operations including: pre-clinical research and development, manufacturing, regulatory and business development. The company is dedicated to continuing to execute its new corporate strategy and will provide timely updates to shareholders.

Financial Results for the Quarter Ended September 30, 2020
Cash Position and Liquidity: At September 30, 2020, cash was approximately $33,000 as compared to approximately $116,000 at June 30, 2020.

Operating Loss: Operating loss for the quarter ended September 30, 2020 and the comparable period in 2019 were both $137,000. For the nine-month period ended September 30, 2020, the operating loss was approximately $377,000 versus $499,000 for the nine months ended September 30, 2019. The decrease in operating loss for 2020 was primarily due to a decrease in professional fees.

INSPYR THERAPEUTICS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)

 
September 30,
 
 
December 31,
 

 
2020
 
 
2019
 

 
(Unaudited)
 
 
 
 

ASSETS

Current assets:

Cash

 
$
4
 
 
$
4
 

Restricted cash

 
 
29
 
 
 
19
 

Total current assets

 
 
33
 
 
 
23
 

Total assets

 
$
33
 
 
$
23
 

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:

Accounts payable

 
$
2,330
 
 
$
2,269
 

Accrued expenses

 
 
1,940
 
 
 
1,866
 

Convertible debentures

 
 
2,143
 
 
 
2,826
 

Derivative liability

 
 
833
 
 
 
1,785
 

Total current liabilities

 
 
7,246
 
 
 
8,746
 

Total liabilities

 
 
7,246
 
 
 
8,746
 

Commitments and contingencies (Note 7)

 
 
–
 
 
 
–
 

Stockholders' deficit:

Convertible preferred stock, undesignated, par value $.0001 per share; 29,986,846 shares authorized, no shares issued and outstanding, respectively

 
 
–
 
 
 
–
 

Convertible preferred stock Series A, par value $.0001 per share; 1,854 shares authorized, 134 shares issued and outstanding, respectively

 
 
–
 
 
 
–
 

Convertible preferred stock Series B, par value $.0001 per share; 1,000 shares authorized, 71 shares issued and outstanding, respectively

 
 
–
 
 
 
–
 

Convertible preferred stock Series C, par value $.0001 per share; 300 shares authorized, 290 shares issued and outstanding, respectively

 
 
–
 
 
 
–
 

Convertible preferred stock Series D, par value $.0001 per share; 5,000 shares authorized, 5,000 shares issued and outstanding, respectively

 
 
–
 
 
 
–
 

Convertible preferred stock Series E, par value $.0001 per share; 5,000 shares authorized, 5,000 shares issued and outstanding, respectively

 
 
 
 
 
 
–
 

Common stock, par value $.0001 per share; 150,000,000

 
 
–
 
 
 
–
 

shares authorized, 40,490,657 and 623,382 shares issued and outstanding, respectively

 
 
4
 
 
 
–
 

Additional paid-in capital

 
 
53,258
 
 
 
51,957
 

Accumulated deficit

 
 
(60,475
)
 
 
(60,680
)

Total stockholders' deficit

 
 
(7,213
)
 
 
(8,723
)

Total liabilities and stockholders' deficit

 
$
33
 
 
$
23
 

INSPYR THERAPEUTICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF LOSSES
(unaudited)
(in thousands, except share and per share data)

 
Three Months Ended September 30,
 
 
Nine Months Ended
September 30,
 

 
2020
 
 
2019
 
 
2020
 
 
2019
 

Operating expenses:

Research and development

 
$
11
 
 
$
11
 
 
$
33
 
 
$
33
 

General and administrative

 
 
126
 
 
 
126
 
 
 
344
 
 
 
466
 

Total operating expenses

 
 
137
 
 
 
137
 
 
 
377
 
 
 
499
 

Loss from operations

 
 
(137
)
 
 
(137
)
 
 
(377
)
 
 
(499
)

Other income (expense):

Gain on change in fair value of derivative liability

 
 
2,024
 
 
 
959
 
 
 
353
 
 
 
640
 

Gain on conversion of debt

 
 
240
 
 
 
–
 
 
 
398
 
 
 
50
 

Interest expense, net

 
 
(21
)
 
 
(401
)
 
 
(169
)
 
 
(683
)

Income (loss) before provision for income taxes

 
 
2,106
 
 
 
421
 
 
 
205
 
 
 
(492
)

Provision for income taxes

 
 
–
 
 
 
–
 
 
 
–
 
 
 
–
 

Net income (loss)

 
$
2,106
 
 
$
421
 
 
$
205
 
 
$
(492
)

Net income (loss) per common share, basic

 
$
0.16
 
 
$
1.75
 
 
$
0.03
 
 
$
(2.08
)

Net income (loss) per common share, diluted

 
$
(0.00
)
 
$
(0.07
)
 
$
(0.00
)
 
$
(2.08
)

Weighted average shares outstanding, basic

 
 
13,344,461
 
 
 
240,000
 
 
 
6,818,722
 
 
 
237,070
 

Weighted average shares outstanding, diluted

 
 
542,003,815
 
 
 
2,047,302
 
 
 
535,478,076
 
 
 
237,070
 

About Inspyr Therapeutics, Inc.
Inspyr Therapeutics, Inc. is a pharmaceutical company focused on the research and development of novel targeted precision therapeutics for the treatment of cancer. Our approach utilizes our proprietary delivery technology to better enhance immuno-modulation for improved therapeutic outcomes. Our potential first-in-class immune-oncology lead asset, RT-AR001, an adenosine receptor antagonist, is differentiated by its novel microparticle formulation that allows for better tumor infiltration and enhanced outcomes when administered intra-tumorally. Our patented portfolio of adenosine receptor antagonists provides flexibility to optimize treatment based on the specific targets found in each type of cancer.

Cautionary Statement Regarding Forward-Looking Information:
This news release contains "forward-looking statements" made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "seek" or "will." Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Inspyr Therapeutic's periodic reports filed with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2019, its Quarterly Reports on Form 10-Q as well as and in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.

CONTACT:

inspyrinfo@gmail.com

SOURCE: Inspyr Therapeutics, Inc.

ReleaseID: 618049

Industry Veteran Brings Deep R&D and Clinical Development Experience to Tarus

NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Tarus Therapeutics Inc., an innovative biotechnology company developing adenosine receptor antagonists for cancer immunotherapy and select non-oncology indications, today announced that Dr. Brian Schwartz, M.D. has joined the company as Acting Chief Medical Officer and Head of the Scientific Advisory Board (SAB).

Dr. Schwartz was Chief Medical Officer at ArQule from 2008, and also Head of Research & Development from 2013, until the company's acquisition by Merck in 2020 for $2.7 billion. Dr. Schwartz has extensive experience in the pharmaceutical and biotechnology industries. Prior to joining ArQule, he was Chief Medical Officer and Senior Vice President, Clinical and Regulatory Affairs, at Ziopharm Oncology where he built and led the clinical, regulatory, and quality assurance departments with responsibilities for the development of new cancer drugs. Prior to Ziopharm, Dr. Schwartz held a number of leadership positions at Bayer Healthcare. At Bayer, Dr. Schwartz was a key physician responsible for the global clinical development of sorafenib (Nexavar®) and led the clinical team through a successful Phase 3 trial in renal cell cancer, leading to U.S. Food and Drug Administration (FDA) approval. He has extensive regulatory experience working with the FDA's Oncology Division, the European Medicines Agency (EMA), and numerous other health authorities. Dr. Schwartz has been involved in multiple clinical and regulatory activities, including Phase 4 studies and interactions with the National Cancer Institute and other oncology cooperative groups. Dr. Schwartz received his medical degree from the University of Pretoria, South Africa, practiced medicine, and worked at the University of Toronto prior to his career in industry. Dr. Schwartz serves on the Boards of Mereo Pharma Group Plc, LifeSci Acquisition Corp and Enlivex Therapeutics Ltd. He is also an advisor to the California Institute of Regenerative Medicine and Pontifax Venture Capital.

"With our IND submissions for multiple programs and indications expected in the near term, Tarus is positioned to rapidly expand its focus on clinical development," said Sushant Kumar, Ph.D., Chief Executive Officer of Tarus Therapeutics. "We are delighted to welcome Dr. Schwartz to Tarus' s leadership team. Dr. Schwartz's deep insight and expertise in clinical development of oncology drugs will be invaluable as we execute our clinical strategy," added Dr. Kumar.

"I am excited to join the Tarus team and look forward to overseeing its research programs and leading the clinical development of multiple programs focused on adenosine receptor antagonism, a promising new area in immuno-oncology," said Dr. Schwartz.

About Tarus Therapeutics Inc.

Tarus is developing small molecule inhibitors of A2AR, A2BR, and Dual A2AR/A2BR inhibitors for cancer immunotherapy and select non-oncology indications. The Company has the most comprehensive portfolio of adenosine receptor antagonists in development, with both first-in-class and best-in-class programs. More information can be found at www.tarustx.com.

Contact:

Tarus Therapeutics, Inc.
Sushant Kumar, PhD
President & CEO
info@tarustx.com

SOURCE: Tarus Therapeutics

ReleaseID: 618007

MONTREAL, QC / ACCESSWIRE / November 24, 2020 / Quebec Precious Metals Corporation ("QPM" or the "Company") (TSXV:QPM)(OTCQB:CJCFF)(FSE:YXEP) is pleased to provide five additional drill results from the 19-hole summer and fall diamond drilling program at La Pointe Extension on the Sakami Project (the "Project") in Quebec's Eeyou Istchee James Bay territory. The program aimed to expand and define the 600 m strike length of mineralization discovered during the 2020 winter campaign at la Pointe Extension. A total of 4,912 m in 19 holes were completed during this campaign. Results from 9 holes are pending.

Normand Champigny, CEO of QPM, stated: "The drilling results at Sakami, and in particular, La Pointe Extension, continue to be consistent and very encouraging. Once again, La Pointe Extension delivered a very long intercept of 1.31 g/t Au over 42 m, and also with a higher grade portion of 1.95 g/t Au over 16.8 m."

Table 1 presents the results of the five holes. Figures 1, 2 and 3 show the drill results from all holes reported to date in plan, longitudinal section and cross-section.

La Pointe deposit and La Pointe Extension discovery

The La Pointe deposit and the new La Pointe Extension discovery are part of a larger 2- kilometre-long mineralized trend on the Project striking SSW-NNE. This discovery has potential kilometre-scale extensions that have been subject to very limited surface exploration and no drilling before 2020. Two high-grade surface grab samples (23.82 g/t Au, 9.52 g/t Au) located 700 m apart further illustrate the potential of this discovery.

The drilling results indicate to date that gold-bearing mineralization at the La Pointe Extension discovery and at La Pointe has a similar geological character: hosted within a volcano-sedimentary sequence of the Yasinski Group (La Grande Subprovince), which is metamorphosed to amphibolite facies and strongly deformed by a regional WSW to ENE event. This sequence is in contact with sedimentary rocks of the Laguiche Group (Opinaca Subprovince) to the east.
The lithologies are composed mainly of 1) biotite-rich and silicified paragneiss with intrusions of granodiorite, tonalite and pegmatite, and 2) amphibolite (metamorphosed sedimentary iron formation and mafic volcanic rock). The gold mineralization is accompanied by disseminated arsenopyrite, pyrite and pyrrhotite and cross-cutting quartz-carbonate veinlets.

The Project provides the Company with a controlling position over a 23-kilometre-long segment of a favourable geological contact and comprises 259 claims (131.1 km2). It is located 570 km north of Val d'Or, Quebec, 120 km east of the municipality of Wemindji, 90 km from the Éléonore gold mine and 47 km northeast of the paved James Bay Road. Good infrastructure is present including major access roads, a hydro-powered electric grid and airports. Drilling can be carried out throughout the year.

The Company also announces that it has re-engaged Red Cloud Financial Services Inc. ("RCFS ") to provide certain marketing services for a period beginning November 18, 2020 and ending January 21, 2021 (see news release dated December 3, 2019 for more details on the engagement). Following such period, if the Company does not elect to terminate the engagement, a fee of $10,000 per month will be payable to RCFS from February 1, 2021 to July 31, 2021.

Quality Assurance/Quality Control

The drilling contract was awarded to Forage Val-d'Or Inc. based in Val-d'Or, Quebec. The hole diameter is NQW. Drilling took place from January 15 to March 24, 2020. Quality assurance and quality control procedures have been implemented to ensure best practices in sampling and analysis of the core samples. The drill core was logged and then split, with one-half sent for assay and the other retained in the core box as a witness sample. Duplicates, standards and blanks were inserted regularly into the sample stream. The samples were delivered, in secure tagged bags, directly to the ALS Minerals laboratory facility in Val-d'Or, Quebec. The samples are weighed and identified prior to sample preparation. All samples are analyzed by fire assay with AA finish on a 30 g sample (0.005-10 ppm Au), with a gravimetric finish for assays over 10 ppm Au.

Qualified Persons

Normand Champigny, Eng., Chief Executive Officer of the Company, and Tony Brisson, P. Geo., Senior Exploration Manager, both Qualified Persons under NI 43- 101 on standards of disclosure for mineral projects, have prepared and approved the technical content of this release.

About Quebec Precious Metals Corporation

QPM is a gold explorer with a large land position in the highly-prospective Eeyou Istchee James Bay territory, Quebec, near Newmont Corporation's Éléonore gold mine. QPM's flagship project is the Sakami project with significant grades and well-defined drill-ready targets. QPM's goal is to rapidly explore this Project to advance it to the mineral resource estimate stage.

For more information, please contact:

Jean-François Meilleur
President
Tel.: 514 951-2730
jfmeilleur@qpmcorp.ca

Normand Champigny
Chief Executive Officer
Tel.: 514 979-4746
nchampigny@qpmcorp.ca

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Table 1: Sakami Project – Summary of significant gold results,
La Pointe deposit and La Pointe Extension discovery – Press release of November 24, 2020

Notes:

All widths are drill indicated core length.
Drilholes are generally planned to intersect mineralization as close to perpendicular to strike as possible.
True widths are estimated to range from 75% to 90% of the down-hole length when drillhole inclination and dip of the mineralized horizons are considered.
All gold values presented are not capped.

La Pointe Extension

Hole #

UTM E

UTM N

Length
(m)

Azimuth
(°)

Dip
(°)

Number
of
samples

From
(m)

To
(m)

Interval
(m)

Au
(g/t)

PT-20-162

374079

5893773

208.5

145

-47

200

98.00

99.00

1.00

5.11

124.00

166.00

42.00

1.31

Including

133.70

150.50

16.80

1.95

182.40

187.80

5.40

0.97

PT-20-165

374117

5893902

363

145

-70

190

40.50

43.00

2.50

0.93

229.30

230.80

1.50

3.52

237.00

240.00

3.00

1.04

244.50

252.80

8.30

0.92

267.00

270.00

3.00

0.33

303.00

307.50

4.50

1.14

PT-20-166

374239

5893899

234

145

-47

172

34.50

36.00

1.50

2.92

90.00

97.20

7.20

1.92

111.50

132.50

21.00

0.61

123.50

132.50

9.00

1.11

PT-20-167

374239

5893899

312

145

-70

216

28.90

30.40

1.50

1.17

50.50

51.80

1.30

1.01

117.00

164.80

47.80

0.53

PT-20-168

374592

5894282

306

145

-57

275

46.90

47.60

0.70

2.77

103.60

116.15

12.55

0.44

182.00

194.00

12.00

1.03

Including

182.00

190.00

8.00

1.44

PT-20-169

374619

5894235

264

145

-45

167

Assays pending

PT-20-170

374540

5894163

234

145

-47

206

Assays pending

PT-20-171

374464

5894106

225

145

-47

152

Assays pending

PT-20-172

374464

5894106

291

145

-65

200

Assays pending

PT-20-173

374369

5894068

288

145

-47

221

Assays pending

PT-20-174

374369

5894068

348

145

-65

270

Assays pending

PT-20-175

374715

5894264

222

145

-47

165

Assays pending

PT-20-176

374715

5894264

21

145

-65

13

Assays pending

PT-20-176A

374715

5894264

303

145

-65

230

Assays pending

SOURCE: Quebec Precious Metals Corporation

ReleaseID: 618142

NORTHVALE, NJ / ACCESSWIRE / November 24, 2020 / Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) received inquiries about a recent ANDA approval listing for nifedipine under the company name of Elite Pharma. This ANDA approval is not a product developed by Elite. Elite’s pipeline has been disclosed in our government filings, our website, or our quarterly conference calls and nifedipine is not one of our projects. Elite’s commercial products are registered with the FDA under Elite Laboratories, Inc., a wholly-owned subsidiary of Elite Pharmaceuticals.

About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which develops niche generic products.  Elite specializes in developing and manufacturing oral, controlled-release drug products.  Elite owns multiple generic products which have been licensed to Lannett Company, Glenmark Pharmaceuticals, Inc., and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. 

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995,  including, without limitation, those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release.  Readers are cautioned that such forward-looking statements involve, without limitation, risks, uncertainties and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These forward-looking statements may include statements regarding the expected timing of approval, if at all, of products by the FDA, and the actions the FDA may require of Elite in order to obtain such approvals. These forward-looking statements are not guarantees of future action or performance. These risks and other factors are discussed, without limitation, in Elite’s filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q, and 8-K. Elite is under no obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations
518-398-6222
Dianne@elitepharma.com 
www.elitepharma.com 

SOURCE: Elite Pharmaceuticals, Inc.

ReleaseID: 618092

TORONTO, ON / ACCESSWIRE / November 24 2020 / GlobeX Data Ltd. (OTCQB:SWISF)(CSE:SWIS) (“GlobeX” or the “Company”), the leader in Swiss hosted secure data management and secure communications, is pleased to report that, following its news release on October 13th 2020 that its Latin America partner, América Móvil S.A.B. de C.V. (NYSE:AMX), has decided to integrate Sekur's encrypted messaging and file transfer application, SekurMessenger with Telcel, América Móvil’s Mexico mobile division; GlobeX can now confirm that technical integration has been completed, and successfully tested.  

The next step for GlobeX is to complete on-boarding integration and perform minor graphical adjustments in order to complete full integration of SekurMessenger with Telcel for sales to start in Mexico. GlobeX estimates that America Movil’s Telcel will start sales as planned by Q1 2021. 

SekurMessenger will first be sold by América Móvil’s Telcel mobile operator in Mexico and will retail in Mexico for 99 MXN/user/month. Once sales in Mexico are underway, there are plans to increase coverage to other countries where América Móvil operates through its Claro brand, such as Colombia and other Latin American countries. GlobeX Data and América Móvil are looking at offering a secure and private alternative to other non-secure messaging applications. The market is geared primarily for business users and privacy conscious consumers. Telcel is the largest mobile operator in Mexico, commanding a market share in excess of 70% with over 75 million mobile subscribers and over 5 million of them being business users. América Móvil is the 7th largest telecom operator in the world with over 277 million mobile subscribers in over 20 countries throughout Latin America and Europe. 

One of the many Privacy and security features of SekurMessenger is that the user does not register with their phone number, eliminating a huge loophole in security and privacy. Just recently, according to an article written by Lindsey O’Donnell and posted on the website threatpost.com on June 5 2020, it was disclosed that WhatsApp phone numbers and users were searchable on Google, creating a massive security and privacy breach. Earlier in the year, an article was written about a similar flaw affecting all businesses, NGOs, UN and non-profit organizations, where WhatsApp Group members were also compromised and searchable in a reverse engineering trick done on Google.  

Recent data breaches in messaging applications and in particular in the WhatsApp application have created a certain urgency for businesses and data privacy advocates to protect their communications form cyber-attacks and identity theft via mobile and desktop devices. 

SekurMessenger eliminates many of the privacy and security risks by not only not requiring a phone number, which would divulge a user’s phone device ID, but also by not social engineering a user’s phone or computer contact list and infecting the contacts by default as well. SekurMessenger issues each user a username and a SM number. The SM number is the contact ID a user would disclose in order for other SM users to be added, since SekurMessenger does not social engineer a user’s address book. The service comes with a self-destruct timer and other features as well, such as GlobeX’s proprietary VirtualVaults and HeliX technologies with all data stored in Swiss hosted encrypted servers. 

Alain Ghiai, CEO of GlobeX Data said: "We are thrilled to have completed the main part of the integration of our SekurMessenger encrypted messaging solution into América Móvil’s core service offerings. Telcel, America Movil’s Mexico mobile operator, has over 75 million users in Mexico and over 5 million of them are business users. The idea here is to offer their corporate and privacy conscious consumer users an alternative to non-secure messaging applications that are in the market. There is an existing demand and we are looking forward to start sales in Q1 2021. Whether you are an SME, an Enterprise or a government organization, you need protection from email cyber-attacks, and identity and data theft. Our strength in using proprietary technology, Swiss privacy laws and no third-party platform such as AWS, MS cloud or Google cloud, puts us in a unique position to provide true privacy and security.” 

América Móvil is a Mexican telecommunications corporation headquartered in Mexico City, Mexico. It is the seventh largest mobile network operator in terms of equity subscribers and one of the largest corporations in the world. América Móvil is a Forbes Global 2000 company.  

According América Móvil Website and public reccords, as of Q1, 2019, América Móvil had 277.4 million wireless subscribers, and 84.3 million fixed revenue generating units (“RGUs”, consisting of fixed voice, fixed data and PayTV units). The company's world headquarters are located in Mexico City, Mexico. Its Mexican subsidiary Telcel is the largest mobile operator in that country, commanding a market share in excess of 70%. The company operates under its Claro subsidiaries in many countries in Latin America and the Caribbean, these include Mexico, Jamaica, the Dominican Republic, El Salvador, Guatemala, Honduras, Nicaragua, Peru, Argentina, Uruguay, Chile, Paraguay, Puerto Rico, Colombia and Ecuador. In Brazil it also operates Claro and other subsidiary Embratel. It owns 14,86% of KPN in the Netherlands and has done a bid on 100% of the shares. The group has also fully consolidated the Telekom Austria Group into its financial reporting, owning 59.7% of its shares and using the Austrian operator to expand América Móvil's European network. The Company has its shares listed on the NYSE under ticker AMX. 

GlobeX’s Data privacy solutions are all hosted in Switzerland, protecting users’ data from any outside data intrusion requests. In Switzerland, the right to privacy is guaranteed in article 13 of the Swiss Federal Constitution. The Federal Act on Data Protection (“FADP”) of 19 June 1992 (in force since 1993) has set up a strict protection of privacy by prohibiting virtually any processing of personal data which is not expressly authorized by the data subjects. The protection is subject to the authority of the Federal Data Protection and Information Commissioner. 

Under Swiss federal law, it is a crime to publish information based on leaked “secret official discussions.” In 2010 the Federal Supreme Court of Switzerland found that IP addresses are personal information and that under Swiss privacy laws they may not be used to track Internet usage without the knowledge of the individuals involved.

About GlobeX Data Ltd. 

GlobeX Data Ltd. is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure data management and secure communications. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted e-mails, and secure communication tools. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide.

On behalf of Management 
GLOBEX DATA LTD.

Alain Ghiai 
President and Chief Executive Officer 
+1.416.644.8690 
corporate@globexdatagroup.com  

For more information please contact GlobeX Data at corporate@globexdatagroup.com or visit us at https://globexdatagroup.com. 

For more information on Sekur visit us at: https://www.sekur.com. 

Forward Looking Information 

This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws ("forward-looking statements"). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "project" and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guaranteeing future performance. GlobeX cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond GlobeX’s control. Such factors include, among other things: risks and uncertainties relating to the future of the Company’s business; the success of marketing and sales efforts of the Company; the projections prepared in house and projections delivered by channel partners; the Company’s ability to complete the necessary software updates; increases in sales as a result of investments software development technology; consumer interest in the Products; future sales plans and strategies; reliance on large channel partners and expectations of renewals to ongoing agreements with these partners; anticipated events and trends; the economy and other future conditions; and other risks and uncertainties, including those described in GlobeX’s prospectus dated May 8, 2019 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, GlobeX undertakes no obligation to publicly update or revise forward-looking information. 

SOURCE: GlobeX Data Ltd.

ReleaseID: 618158

DESTIN, FL / ACCESSWIRE / November 24, 2020 / Combat sports fans in Germany will now get to enjoy XFC 43 from the comfort of their homes, as XFC MMA's historic relaunch event will air on ProSieben's Ran FIGHTING Channel.

ProSieben is the largest broadcaster in Germany.

XFC President Myron Molotky is excited to see his organization expand its reach into Germany, Europe's third most populated country.

"Germany has produced some of MMA's most exciting athletes, and certainly some of the sport's biggest fans. We couldn't be more excited to add ProSieben to our ever-expanding network of broadcast partners, and we know their audience is going to absolutely love XFC 43, and crave more action in the Hexagon after that."

The time of the broadcast is to be determined.

About XFC
Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol DKMR. Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America – Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL – the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.

Press Contact:
Jen Wenk, APR
jenwenkpr@gmail.com
208.421.2919

SOURCE: Xtreme Fighting Championships, Inc.

ReleaseID: 618078

SANTA CLARA, CA / ACCESSWIRE / November 24, 2020 / SPI Energy Co., Ltd., (NASDAQ:SPI) (the "Company"), a global renewable energy company and provider of photovoltaic (PV) and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors, today announced Phoenix Motorcars, which was recently acquired by the Company's wholly owned subsidiary, EdisonFuture, delivered its second all-electric ZEUS Z-400 shuttle to the City of Santa Cruz.

The two ZEUS shuttles, built on the Ford E-450 chassis with a Starcraft Bus body by Phoenix Motorcars, will serve the Santa Cruz trolley, replacing their existing wooden trolleys and helping to promote the City's sustainability goals. The all electric zero emission shuttle bus was funded in part by the Monterey Bay Air Resources District (MBARD) Clean Air Management Program and the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP) program.

"MBARD is proud to be working with our local municipalities like the City of Santa Cruz to help clean the air quality in our coastal communities. Through our Air Bill 2766 Funding, we have helped Santa Cruz adopt these Phoenix Motorcars ZEUS Shuttles into their fleet and look forward to future deployments," said Alan Romero, Air Quality Planner at Monterey Bay Air Resources District.

The shuttle bus is equipped with a 105-kWh battery pack offering up to 110 mile range and can be fully charged in about three hours with a 50 kW Level III charger. Staying in harmony with the old trollies, the new electric shuttle buses from Phoenix Motorcars feature faux wooden interiors, while being equipped with 16 seats and two wheelchair accessible seats. The ZEUS shuttle bus, as compared to its equivalent fossil fueled alternatives, will reduce atmospheric emissions by ~61 tons annually, reduce maintenance costs by 75% and fuel costs by 80%.

"We are thrilled to be receiving our two electric shuttles from Phoenix Motorcars. They will replace the old trolleys and we are certain customers will love the quiet, smooth and emission free ride. It has been a pleasure working with the Phoenix team," says Amanda Rotella, Economic Development Coordinator at The City of Santa Cruz.

"Zero emission transportation is an integral part of building a sustainable future and it's great to see the City of Santa Cruz being an early adopter. Operating the ZEUS all-electric shuttle bus from Phoenix will provide significant emission savings and cost saving opportunities to the customer. At SPI, our focus has always been sustainable development and we look forward to expanding Phoenix's range of zero emission products to meet varied fleet requirements," stated Xiaofeng Peng, Chairman and CEO of SPI Energy.

Phoenix Motorcars is a leader in developing medium-duty electric vehicles for commercial markets with a primary focus on class 3 & 4 vehicles. Phoenix Motorcars strives to provide fleets with clean transportation and renewable energy through advanced technology solutions and remains committed to excellence in electric vehicle innovation. Phoenix Motorcars offers a range of vehicle configurations, including shuttle buses, utility trucks, service trucks, flatbed trucks, walk-in vans, cargo trucks and school buses.

For more information, please visit www.phoenixmotorcars.com

About SPI Energy

SPI Energy Co., Ltd. (SPI) is a global renewable energy company and provider of photovoltaic (PV) and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors. The Company provides a full spectrum of EPC services to third party project developers, as well as develops, owns and operates solar projects that sell electricity to the grid in multiple countries, including the U.S., the U.K., Greece, Japan and Italy. The Company has its US headquarters in Santa Clara, California and maintains global operations in Asia, Europe, North America and Australia. SPI is also targeting strategic investment opportunities in green industries such as battery storage and charging stations, leveraging the Company's expertise and growing base of cash flow from solar projects and funding development of projects in agriculture and other markets with significant growth potential.

For more information on SPI Energy and its subsidiaries, the Company recommends that stockholders, investors and any other interested parties read the Company's public filings and press releases available under the Investor Relations section at www.SPIgroups.com or available at www.sec.gov.

Forward-Looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations depending upon a number of factors. These factors include, among others, the coronavirus (COVID-19) and the effects of the outbreak and actions taken in connection therewith, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described in the "Risk Factors" section of the Company's annual report filed on Form 20-F filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.

Contact:

SPI Energy Co., Ltd.
IR Department
Email: ir@spigroups.com

Dave Gentry
RedChipCompanies, Inc.
Phone:(407) 491-4498
dave@redchip.com

SOURCE: SPI Energy Co., Ltd.

ReleaseID: 618132

Company Establishes Strategic Partnerships with San Diego County Builders; Maintains Pipeline of 500 Roofing & Solar Installations at New Housing Developments

EL CAJON, CA / ACCESSWIRE / November 24, 2020 / Solar Integrated Roofing Corp. (OTCPINK:SIRC), an integrated, single-source solar power and roofing systems installation company, announced today that it has partnered with several San Diego county home builders to expand its addressable opportunity into the new home market, marking the Company's initial entry into servicing large, new residential housing developments.

Now that state regulations require solar to be integrated into the roof of every new home in the State of California, new housing developments present not only a significant roofing installation opportunity but a mandated minimum solar installation opportunity as well. The Company expects each new home with roofing, and the minimum required solar installation will generate at least $13,000 in revenue.

Solar Integrated Roofing has established partnerships with several small and medium San Diego county builders to expand into this new market, having already secured approximately 500 new homes in its project pipeline. This will provide Solar Integrated Roofing with an estimated $6.5 million in revenue from this first lot of homes.

California's new home market, according to the San Diego Tribune, averages 80,000 new homes per year. Requiring solar integration, as mentioned, on each new home will help reduce the current rolling brownouts and blackouts in California resulting from the currently limited energy supply.

"We are pleased to announce our strategic partnership with local builders to enter the new home development market, presenting a significant opportunity to leverage the full breadth of our suite of services," said David Massey, Chief Executive Officer of Solar Integrated Roofing Corporation. "In addition to the roofing and solar revenue from each new housing development, we maintain the upside opportunity to sell the end home buyer additional solar or battery storage solutions, creating an exciting new sales pipeline for our growing team. I look forward to continued growth into 2021 and beyond as we work to create value for our shareholders."

About Solar Integrated Roofing Corp.

Solar Integrated Roofing Corporation (OTCPINK:SIRC) is an integrated, single-source solar power and roofing systems installation company specializing in commercial and residential properties in the Southern California market. For more information, please visit the Company's website at www.solarintegratedroofingcorp.com.

Forward-Looking Statements

Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition, and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing, and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market, and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update the information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.

Investor Relations Contact:
Lucas A. Zimmerman
Senior Vice President
MZ North America
Main: 949-259-4987
SIRC@mzgroup.us
www.mzgroup.us

SOURCE: SIRC

ReleaseID: 618014